Home › Myeloproliferative Neoplasms › Connecticut › New Haven
Myeloproliferative Neoplasms clinical trials in New Haven, CT
4 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Yale University, New Haven
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Yale University, New Haven
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Yale Cancer Center, New Haven
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Milwaukee, WI10 studies
- Miami, FL10 studies
- Seattle, WA9 studies
- Baldwin Park, CA9 studies
- Durham, NC9 studies
- Chicago, IL9 studies
- St. Louis, MO8 studies
- Cleveland, OH8 studies
- Birmingham, AL8 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)34 studies
- Lung Cancer23 studies
- Metastatic Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Prostate Cancer21 studies
- Colorectal Cancer21 studies
- Ovarian Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.